Regular use of aspirin and pancreatic cancer risk

Menezes, Ravi J.; Huber, Kenneth R.; Mahoney, Martin C.; Moysich, Kirsten B.
January 2002
BMC Public Health;2002, Vol. 2 Issue 1, p18
Academic Journal
Background: Regular use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been consistently associated with reduced risk of colorectal cancer and adenoma, and there is some evidence for a protective effect for other types of cancer. As experimental studies reveal a possible role for NSAIDs is reducing the risk of pancreatic cancer, epidemiological studies examining similar associations in human populations become more important. Methods: In this hospital-based case-control study, 194 patients with pancreatic cancer were compared to 582 age and sex-matched patients with non-neoplastic conditions to examine the association between aspirin use and risk of pancreatic cancer. All participants received medical services at the Roswell Park Cancer Institute in Buffalo, NY and completed a comprehensive epidemiologic questionnaire that included information on demographics, lifestyle factors and medical history as well as frequency and duration of aspirin use. Patients using at least one tablet per week for at least six months were classified as regular aspirin users. Unconditional logistic regression was used to compute crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs). Results: Pancreatic cancer risk in aspirin users was not changed relative to non-users (adjusted OR = 1.00; 95% CI 0.72-1.39). No significant change in risk was found in relation to greater frequency or prolonged duration of use, in the total sample or in either gender. Conclusions: These data suggest that regular aspirin use may not be associated with lower risk of pancreatic cancer.


Related Articles

  • Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials. Chen, Han; Zhou, Xiaoying; Chen, Tao; Liu, Bingtuan; Jin, Wujuan; Gu, Huiyuan; Hong, Tianyuan; Zhang, Guoxin // Diabetes Therapy;Dec2016, Vol. 7 Issue 4, p725 

    Introduction: The present study aims to evaluate the risk of pancreatic cancer with incretin-based therapy among patients with type 2 diabetes mellitus (T2DM). Methods: We searched EMBASE, MEDLINE, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for eligible studies...

  • Study finds aspirin may prevent certain breast cancers.  // Mayo Clinic Health Letter;Sep2004, Vol. 22 Issue 9, p4 

    Discusses a research about the role of aspirin in lowering the risk of developing breast cancer. Reference to a study published in the May 26, 2004 issue of the "Journal of the American Medical Association"; Suggestion that anti-inflammatory drugs have cancer-protective benefits.

  • Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Larsson, S. C.; Giovannucci, E.; Wolk, A. // British Journal of Cancer;11/6/2006, Vol. 95 Issue 9, p1277 

    In a prospective cohort study of 74 250 Swedish women and men, with 7.2 years of follow-up and 705 incident colorectal cancer cases, long duration of aspirin use (>20 years) was associated with a reduced risk of colorectal cancer (multivariate rate ratio: 0.65; 95% confidence interval:...

  • Some analgesics may be associated with renal cancer.  // Reactions Weekly;5/30/2009, Issue 1254, p2 

    The article focuses on a study which examined the link between paracetamol and nonsteroidal anti-inflammatory drugs (NSAID) administration and an increased risk of renal cancer. The study utilized data from the Nurses' Health Study and Health Professionals Follow-up Study. Study authors found...

  • Aspirin Users Attending for NHS Bowel Cancer Screening Have Less Colorectal Neoplasia: Chemoprevention or False-Positive Faecal Occult Blood Testing? Lee, Thomas J.W.; Hull, Mark A.; Rajasekhar, Praveen T.; Clifford, Gayle M.; Ritchie, Mary; James, Peter; McNally, Richard J.Q.; Rutter, Matthew D.; Rees, Colin J. // Digestion;2012, Vol. 85 Issue 4, p278 

    Objective: The NHS Bowel Cancer Screening Programme (BCSP) uses faecal occult blood (FOB) testing to select patients aged 60-69 years for colonoscopy. Aim: To examine the association between aspirin use and the detection of colorectal neoplasia in screened patients undergoing colonoscopy....

  • Hereditary pancreatitis and the risk of pancreatic cancer. Lowenfels, Albert B.; Maisonneuve, Patrick // JNCI: Journal of the National Cancer Institute;03/19/97, Vol. 89 Issue 6, p442 

    Assesses the frequency of pancreatic cancer and other tumors in patients with hereditary form of pancreatitis. Criteria for patient eligibility; Estimation using the standardized incidence ratio; Transmission pattern of hereditary pancreatitis.

  • Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status. Marshall, Sarah F.; Bernstein, Leslie; Anton-Culver, Hoda; Deapen, Dennis; Horn-Ross, Pamela L.; Mohrenweiser, Harvey; Peel, David; Pinder, Rich; Purdie, David M.; Reynolds, Peggy; Stram, Dan; West, Dee; Wright, William E.; Ziogas, Argyrios; Ross, Ronald K. // JNCI: Journal of the National Cancer Institute;6/1/2005, Vol. 97 Issue 11, p805 

    Background: Epidemiologic studies oft the association between nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, and breast cancer risk have yielded inconsistent results. We investigated the association of NSAID use with risk of breast cancer in the California Teachers...

  • RESEARCH.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/3/2010, Vol. 341 Issue 7762, p38 

    The article discusses various papers published within the issue including a study on the link between proximity to mobile phone base stations and cancer risk, a trial on home based health education, and another study on the association between acid suppressants and postoperative pneumonia.

  • substance abuse Creatine=Cance.  // Scholastic Choices;Apr2001, Vol. 16 Issue 7, p4 

    Reports on the study conducted by scientists from the French Medical Agency for Food Safety which revealed a link between creatine use and cancer formation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics